Krystal Biotech to Present at William Blair Biotech Focus Conference 2022

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS), a leader in redosable gene therapy, will participate in the William Blair Biotech Focus Conference 2022 on July 12-13 in New York. CEO Krish Krishnan will engage in a fireside chat and lead investor meetings on July 13. A webcast of the event will be available starting 9 AM ET on July 11. The company focuses on developing innovative therapies for serious diseases, particularly rare skin and lung conditions. For more information, visit Krystal Biotech's website.

PITTSBURGH, July 06, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, announced today that the Company will participate in the William Blair Biotech Focus Conference 2022 taking place in New York from July 12-13.

Krish Krishnan, Chairman and Chief Executive Officer, will participate in a fireside chat during the conference and host investor meetings on July 13.

A webcast of the event will be available here beginning at 9am ET on July 11 and posted on the Investor section of the Company’s website.

About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a pivotal-stage gene therapy company leveraging its proprietary, redosable gene therapy platform and in-house manufacturing capabilities to develop life-changing medicines for patients with serious diseases, including rare diseases in skin, lung, and other areas. For more information please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and Twitter.

CONTACTS:
Investors and Media:
Meg Dodge
Krystal Biotech
mdodge@krystalbio.com

Source: Krystal Biotech, Inc.

FAQ

When will Krystal Biotech participate in the William Blair Biotech Focus Conference?

Krystal Biotech will participate in the William Blair Biotech Focus Conference on July 12-13, 2022.

Who is speaking at the William Blair Biotech Focus Conference for Krystal Biotech?

CEO Krish Krishnan will participate in a fireside chat during the conference.

What is the schedule for investor meetings at the conference?

Investor meetings for Krystal Biotech will be held on July 13, 2022.

Where can I find the webcast for Krystal Biotech's conference participation?

The webcast will be available starting 9 AM ET on July 11, 2022, on Krystal Biotech's website.

What type of therapies does Krystal Biotech focus on?

Krystal Biotech focuses on developing redosable gene therapies for serious diseases, including rare skin and lung diseases.